Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 159,859 | 129,883 | 208,343 | 69,429 | 78,530 |
| Marketable Securities | 506,361 | 247,221 | 182,915 | 221,165 | 247,544 |
| Receivables | 4,609 | 11,600 | 4,965 | 2,370 | 1,408 |
| TOTAL | $677,547 | $393,185 | $401,817 | $299,465 | $332,280 |
| Non-Current Assets | |||||
| PPE Net | 28,409 | 25,986 | 27,598 | 29,052 | 29,336 |
| Other Non-Current Assets | 30,472 | 29,488 | 30,426 | 31,069 | 31,583 |
| TOTAL | $58,881 | $55,474 | $58,024 | $60,121 | $60,919 |
| Total Assets | $736,428 | $448,659 | $459,841 | $359,586 | $393,199 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,900 | 3,550 | 14,509 | 5,581 | 6,489 |
| Accrued Expenses | 25,594 | 26,694 | 17,902 | 13,767 | 16,287 |
| TOTAL | $71,036 | $64,212 | $61,443 | $41,852 | $59,216 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 33,059 | 29,571 | 24,791 | 18,410 | 32,575 |
| Other Non-Current Liabilities | 34,581 | 34,794 | 35,927 | 37,037 | 37,999 |
| TOTAL | $143,476 | $151,391 | $152,561 | $49,654 | $58,823 |
| Total Liabilities | $214,512 | $215,603 | $214,004 | $91,506 | $118,039 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 84,479 | 80,016 | 65,118 | 61,759 | 61,510 |
| Common Shares | 8 | 7 | 6 | 6 | 6 |
| Retained earnings | -521,717 | -477,214 | -431,079 | -403,998 | -391,703 |
| Other shareholders' equity | -4,746 | -3,827 | -3,247 | -3,373 | -3,329 |
| TOTAL | $521,916 | $233,056 | $245,837 | $268,080 | $275,160 |
| Total Liabilities And Equity | $736,428 | $448,659 | $459,841 | $359,586 | $393,199 |